Department of Nutrition Research, National Nutrition and Food Technology Research Institute, and Faculty of Nutrition Science and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Diabetes Care. 2013 Mar;36(3):550-6. doi: 10.2337/dc12-0919. Epub 2012 Nov 16.
Interpopulation as well as interindividual variations in response to vitamin D intake commonly observed in subjects with type 2 diabetes may be related to genetic makeup. One of the candidate genes potentially responsible for this diversity is vitamin D receptor (VDR). This study aimed to investigate the interactive effect of VDR Fok-I polymorphism and vitamin D intake on diverse aspects of diabetic host response.
Glycemic status, lipid profiles, inflammatory biomarkers, and VDR Fok-I genotypes were determined in diabetic subjects (n = 140) who participated in a randomized controlled trial. Participants consumed two 250-mL bottles per day of yogurt drink (doogh) fortified with 500 IU vitamin D/250 mL for 12 weeks.
Mean serum 25(OH)D increased by ~30 nmol/L (P < 0.001). The time × intervention effect was significant for 25(OH)D (P = 0.030), HDL (P = 0.011), high-sensitivity C-reactive protein (hsCRP) (P < 0.001), interleukin (IL)-4 (P = 0.008), and IL-6 (P = 0.017) among the genotypic groups. The alleles were defined as ''F'' or ''f'' depending on the absence or presence of the restriction site, respectively. The least increment in 25(OH)D was in ff (23.0 ± 3.8 nmol/L) compared with Ff (31.2 ± 3.4 nmol/L) and FF (35.6 ± 2.7 nmol/L) (P for trend = 0.009), but only the difference between ff and FF was significant (P = 0.023). FF group had the largest decrement of both hsCRP and IL-6 compared with Ff (P < 0.001 and P = 0.038) and ff (P = 0.010 and P = 0.048), respectively.
We concluded that those of VDR ff genotype may be regarded as "low responders" to vitamin D intake in terms of response of circulating 25(OH)D and certain inflammatory biomarkers. A nutrigenetic approach may, therefore, be needed to protect diabetic patients from vitamin D deficiency.
2 型糖尿病患者对维生素 D 摄入的反应存在个体间和群体间的差异,这种差异可能与遗传因素有关。潜在导致这种多样性的候选基因之一是维生素 D 受体(VDR)。本研究旨在探讨 VDR Fok-I 多态性与维生素 D 摄入对糖尿病宿主反应多样性的交互作用。
140 例糖尿病患者参加了一项随机对照试验,测定了他们的血糖状态、血脂谱、炎症生物标志物和 VDR Fok-I 基因型。参与者每天饮用 2 瓶 250 毫升强化了 500IU 维生素 D/250 毫升的酸奶饮料(doogh),持续 12 周。
血清 25(OH)D 平均增加约 30nmol/L(P<0.001)。25(OH)D(P=0.030)、高密度脂蛋白(HDL)(P=0.011)、高敏 C 反应蛋白(hsCRP)(P<0.001)、白细胞介素(IL)-4(P=0.008)和 IL-6(P=0.017)的时间×干预效应有统计学意义。根据有无限制酶切位点,等位基因分别定义为“F”或“f”。与 Ff(31.2±3.4nmol/L)和 FF(35.6±2.7nmol/L)相比,ff 基因型的 25(OH)D 增加量最小(23.0±3.8nmol/L)(P 趋势=0.009),但只有 ff 与 FF 之间的差异有统计学意义(P=0.023)。FF 组的 hsCRP 和 IL-6 降幅均大于 Ff(P<0.001 和 P=0.038)和 ff(P=0.010 和 P=0.048)。
我们得出结论,VDR ff 基因型的人可能被视为“低反应者”,因为他们对循环 25(OH)D 和某些炎症生物标志物的维生素 D 摄入反应不佳。因此,可能需要一种营养遗传学方法来保护糖尿病患者免受维生素 D 缺乏的影响。